Science Explorer Interactive view Map
Company · Needham · United States

Verastem (United States)

Research works
84
▼ 40% vs 2013–17
Citations
1.6k
18.9 per fractional work
Top-10% rate
18.7%
record average 16.5%
Open access
22%
world 28%

Not ranked overall: Verastem (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.00× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 3.40× its world share, 1 worksImmunology and Micro…Neuroscience: 0.69× its world share, 0 worksNeuroscienceChemistry: 1.43× its world share, 0 worksChemistryEngineering: 0.09× its world share, 0 worksEngineeringMedicine: 3.39× its world share, 13 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.0×. Every wedge is a field page.

Who are the top researchers at Verastem (United States)?

Ranked on the composite score, David T. Weaver, Jonathan A. Pachter and Vihren N. Kolev lead among researchers whose main affiliation is Verastem (United States).

  1. 1 David T. Weaver United States · #266,218 worldwide 158 citations · 39 works
  2. 2 Jonathan A. Pachter United States · #750,836 worldwide 130 citations · 51 works
  3. 3 Vihren N. Kolev United States · #950,906 worldwide 25 citations · 17 works
All ranked researchers at Verastem (United States)

Which keywords describe research at Verastem (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Chemotherapy, Clinical Trials, Metastasis, Immune Response, Tumor Microenvironment, Melanoma and Oncogenic Mutations.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Cancer Therapy3▲ 29×6 topics
  2. Chemotherapy3▲ 22×7 topics
  3. Clinical Trials2▲ 18×4 topics
  4. Immune Response2▲ 21×3 topics
  5. Metastasis2▲ 35×4 topics
  6. Melanoma2▲ 185×2 topics
  7. Tumor Microenvironment2▲ 25×5 topics
  8. Cancer2▲ 7.4×8 topics
  9. Cell Proliferation2▲ 114×2 topics
  10. Oncogenic Mutations2▲ 402×2 topics
  11. BRAF gene2▲ 591×1 topic
  12. MAP Kinase2▲ 591×1 topic
  13. Immunotherapy2▲ 11×7 topics
  14. Targeted Therapy2▲ 36×3 topics
  15. Angiogenesis2▲ 23×5 topics
  16. Cancer Progression2▲ 39×3 topics
  17. Inflammation1▲ 3.3×6 topics
  18. Breast Cancer1▲ 28×3 topics
  19. ALK Inhibitors1▲ 92×1 topic
  20. Biomarkers1▲ 8.9×2 topics
  21. EGFR Mutations1▲ 92×1 topic
  22. Extracellular Matrix1▲ 32×3 topics
  23. Genomic Analysis1▲ 21×1 topic
  24. Ovarian Cancer1▲ 59×1 topic
  25. Pim Oncogenes1▲ 278×1 topic
  26. Tumorigenesis1▲ 135×1 topic

Which research topics does Verastem (United States) publish most on?

By volume in 2022–2025: Melanoma and MAPK Pathways, Lung Cancer Treatments and Mutations, Ovarian cancer diagnosis and treatment and Cancer Mechanisms and Therapy.

  1. 1 Melanoma and MAPK Pathways Molecular Biology 2 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  3. 3 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
  4. 4 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 1 works
  5. 5 Cell Adhesion Molecules Research Immunology and Allergy 1 works
  6. 6 Colorectal Cancer Treatments and Studies Oncology 1 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 1 works
  8. 8 Chronic Myeloid Leukemia Treatments Hematology 0 works
  9. 9 Peptidase Inhibition and Analysis Oncology 0 works
  10. 10 Chronic Lymphocytic Leukemia Research Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available22.2%not open77.8%

World: 28% of research is openly available.

with international co-authors18.9%domestic only81.1%

World: 19% is written across borders.

How has Verastem (United States)'s research output changed?

Output in 2018–2022 was 40% lower than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Needham

All research institutions in Needham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.